Skip to content

Clinical trials

Completed Phase 1/2 Liver Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 1/2 Status: Completed Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20021
20033
20042
20051
20061
20072
20081
20092
20112
20122
20132
20144
20156
20162
20172
20181
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fuda Cancer Hospital, Guangzhou8
Alliance for Clinical Trials in Oncology2
Jonsson Comprehensive Cancer Center2
M.D. Anderson Cancer Center2
National Cancer Institute (NCI)2
Arbutus Biopharma Corporation1
Basilea Pharmaceutica1
Bristol-Myers Squibb1
Centre Leon Berard1
Chinese PLA General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms45
Carcinoma, Hepatocellular20
Neoplasms5
Pancreatic Neoplasms5
Bile Duct Neoplasms4
Breast Neoplasms4
Head and Neck Neoplasms4
Lung Neoplasms4
Cholangiocarcinoma3
Colonic Neoplasms3

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.